« Back to Members

Micro-Sphere SA

Micro-Sphere SA

Micro-Sphere is located in southern Switzerland. Through practical experience gained over the past decade, Micro-Sphere has advanced its know-how in spray drying techniques for almost 100 different active pharmaceutical ingredients (API) used in the pharmaceutical industry today. All operations are carried out in accordance with cGMP standards and in full compliance with the regulatory requirements of the Swiss (Swissmedic), European (EMA) and United States (US-FDA) health authorities.
Micro-Sphere also has extensive demonstrated expertise in the field of high-potency active pharmaceutical ingredients (HPAIs), particularly with dry powders for inhalation and water-insoluble molecules for nanoemulsion dispersion. However, with its core business being contract manufacturing and development of pharmaceutical products, Micro-Sphere also has development capabilities in cosmetics, nutraceuticals and natural products, as well as medical devices.
Lacto-Sphere® is Micro-Sphere’s proprietary Lactose based on the raw material lactose monohydrate of US origin, thus BSE/TSE free. Lacto-Sphere is developed specifically for respiratory formulations and is produced in two variations: Lacto-Sphere MM3 (average particle size 3 μm) and Lacto-Sphere MM50 (average particle size 50 μm).

Via Cantonale 77
6998 Monteggio
T.: +41 91 986 70 70
F.: +41 91 986 70 71
http://www.micro-sphere.com
info@micro-sphere.com

  • Main activities
    Drug Product CMO
    Drug Substance CMO
    Other CMO Activities

  • Drug stages
    Pre-clinical
    Phase I - Phase III
    Registration
    Market
    Generic Plus (505B2)
    Generic

  • Therapeutic areas
    Cancer supportive therapy
    Cardiology
    Cardiovascular
    CNS
    Dermatology
    Diabetes
    Endocronology
    Gastrointestinal
    Gynaecology
    Infertility
    Metabolism
    Oncology
    Ophtalmology
    Pain
    Respiratory
    Rheumatology

  • Markets
    CH
    EU Top 5
    Rest of Europe
    USA and Canada
    MENA
    ASEAN
    Australia
    India
    Japan

  • Drug product forms
    Aerosol
    Inhaler
    Injectable
    Oral (solid)
    Oral (liquid)
    Spray
    Topical

  • Drug substance type
    APIs (1-10kgs/batch)
    APIs (20-200kgs/batch)
    APIs (>200kgs/batch)
    HPAI 10-100g/batch
    HPAI 0.2-5kgs/batch
    HPAI 6-20kgs/batch
    HPAI >20kgs/batch
    HPAI Cat. 3 safebridge
    Antibiotics
    Steroids

  • Other activities (non pharma)
    Analytical Services
    Cosmetics
    Medical Devices
    Medical Food
    Natural Products
    Nutraceuticals
    Pre-formulation

  • Other CMO activities
    Analytical Services
    Co-development
    Micronization
    Pre-formulation
    Spray-Drying
    Other